Webinar Key success criteria for hearing (pre)clinical trials

WEBINAR: KEY SUCCESS CRITERIA FOR HEARING (PRE)CLINICAL TRIALS

In collaboration with CILcare, we presented the webinar: Key success criteria for hearing (pre)clinical trials

During this webinar, which is host by Dr. Helen Blackshaw, Prof. Anne Schilder and Dr. Wahid Awad discussed the following topics :

Design of the preclinical studies -models, drug regimen, read out/measures- to support the clinical indication
Translation from preclinical to clinical with a link to
- trial design
- patient selection how to choose endpoints/outcome measure/diagnostics
- access to populations: recruitment, feasibility, networks

WATCH REPLAY

More information about ENT Clinical and CILcare, you will find below.

ENT CLINICAL:THE EXPERT CLINICAL CRO FOR ENT, HEARING AND BALANCE RESEARCH

ENT Clinical is an expert CRO for ENT, hearing and balance research. With a strong scientific background and substantial experience in the public, private, academic and commercial pharma sectors, ENT Clinical works closely with an extensive international clinical network to offer clients tailored advice throughout the development of clinical research programs. Embedded within Julius Clinical, ENT Clinical has the operational capacity of a large CRO, ensuring successful delivery of high quality clinical trials across the field of ENT, hearing and balance.

Click here for more information about ENT Clinical.

CILcare is a world’s leading R&D services company specialized in ear disorders. Based in Montpellier, Boston, and Paris, CILcare has become the one-stop partner for pharmaceutical industries, biotechs and medtechs developing novel therapies for people with hearing and otic disorders. If the importance of investigating tinnitus and hearing loss is pointed out, the underlying fundamental knowledge bases on animal models and the translational mindset are severely lacking. CILcare’s offer fills this gap by providing means to validate hypothesis towards solutions able to prevent and to reduce hearing disorders. CILcare designs and performs pharmacokinetics, efficacy, and GLP ototoxicity studies to assess drugs, medical devices, cell & gene therapies, on hearing loss, tinnitus, and otitis.

Click here for more information about CILcare

WEBINAR: KEY SUCCESS CRITERIA FOR HEARING (PRE)CLINICAL TRIALS

Contact us

Stay in touch

Privacy Policy

WEBINAR: KEY SUCCESS CRITERIA FOR HEARING (PRE)CLINICAL TRIALS

Contact us

Stay in touch

Privacy Policy

Cookie and Privacy Settings